CytoDyn (CYDY) Operating Expenses (2010 - 2026)
CytoDyn's (CYDY) quarterly Operating Expenses came in at $6.3 million in Q1 2026, up 57.46% YoY from $4.0 million in Q1 2025, and down 70.94% on a QoQ basis from $21.7 million in Q4 2025.
CytoDyn (CYDY) Operating Expenses (2010 - 2026) Analysis & Trends
CytoDyn (CYDY) has 17 years of Operating Expenses data on file, last reported at $6.3 million in Q1 2026.
- Quarterly Operating Expenses rose 57.46% year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $38.0 million (up 569.57% YoY) and the FY2025 annual result came in at -$9.7 million, down 153.5% from the prior year.
- Operating Expenses eased to $6.3 million in Q1 2026, from $21.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $79.0 million in Q2 2022 to a low of -$22.4 million in Q3 2024.
- A 5-year average of $10.6 million and a median of $4.9 million in 2025 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2024 — Operating Expenses sank 586.49% — and 2025, when it soared 485.06%.
- Tracing CYDY's Operating Expenses over 5 years: stood at $23.2 million in 2022, then sank by 85.33% to $3.4 million in 2023, then gained by 9.09% to $3.7 million in 2024, then soared by 485.06% to $21.7 million in 2025, then slumped by 70.94% to $6.3 million in 2026.
- The last three Operating Expenses figures came in at $6.3 million (Q1 2026), $21.7 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - | 6.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 6.30 Mn |
| Nov 30, 2025 | 21.69 Mn |
| Aug 31, 2025 | 4.95 Mn |
| May 31, 2025 | 5.07 Mn |
| Feb 28, 2025 | 4.00 Mn |
| Nov 30, 2024 | 3.71 Mn |
| Aug 31, 2024 | -22.44 Mn |
| May 31, 2024 | 6.63 Mn |
| Feb 29, 2024 | 3.41 Mn |
| Nov 30, 2023 | 3.40 Mn |
| Aug 31, 2023 | 4.61 Mn |
| May 31, 2023 | 3.78 Mn |
| Feb 28, 2023 | 3.92 Mn |
| Nov 30, 2022 | 23.16 Mn |
| Aug 31, 2022 | 9.71 Mn |
| May 31, 2022 | 79.05 Mn |
| Feb 28, 2022 | 19.40 Mn |
| Nov 30, 2021 | 25.50 Mn |
| Aug 31, 2021 | 21.68 Mn |
| May 31, 2021 | 23.64 Mn |